Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
Bing Yu(Center for Cancer Research), Ji Luo(Central South University), Richard J. Simpson(University of Arizona), Garmen Yuen(Center for Cancer Research), Jordan L. Smith(University of Massachusetts Chan Medical School), David K. Ann(City Of Hope National Medical Center), Stephen Swatkoski(National Institutes of Health), Chih-Shia Lee(Center for Cancer Research), Chad J. Creighton(Baylor College of Medicine), Dennis Hsu(University of Pittsburgh Medical Center), Alesia Holly(Cancer Institute (WIA)), Valentin Giroux(Center for Cancer Research), William D. Figg(National Cancer Institute), Marjan Guček(National Heart Lung and Blood Institute), Junqiu Yue(Center for Cancer Research), Liam C. Lee(Center for Cancer Research)
Cited by 75
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k